Acanthus Research Inc. (ARI) is a leading Canadian company developing and manufacturing pharmaceutical reference standards. Our team of experienced scientists is adding new products to our portfolio every day, every week, every month.
Below are the highlights of products added in March 2019. All products are fully certified with detailed certificates of analysis.
Nintedanib Acid; Catalogue No. B-71114-0005
Nintedanib N,N’-Dioxide; Catalogue No. B-71120-0002
Nintedanib Enamine N-Methyl Impurity; Catalogue No. B-71120-0003
Nintedanib N-Methyl Aniline Impurity; Catalogue No. B-71120-0004
Nintedanib Indoline N-Acetyl Impurity; Catalogue No. B-71120-0005
Nintedanib Aniline N-Acetyl Impurity; Catalogue No. B-71120-0006
Nintedanib Piperazine Dimer; Catalogue No. B-71120-0007
alpha-Hydroxy Trimethoprim; Catalogue No. T-90226-1
C-alpha-NAC-Trimethoprim; Catalogue No. T-81011-1
Nitroxoline-d4; Catalogue No. N-81023-1